Development of the Thermophilic Filamentous Fungus Thermothelomyces heterothallica C1 into a prominent human and animal vaccines production platform
Conference Dates
May 19 - 24, 2024
Abstract
Please click Additional Files below to see the full abstract.
Recommended Citation
Mark Emalfarb, "Development of the Thermophilic Filamentous Fungus Thermothelomyces heterothallica C1 into a prominent human and animal vaccines production platform" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/57
53.pdf (1999 kB)
COinS